BenQ Medical Technology Corporation (4116) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BenQ Medical Technology Corporation (4116:TWSE), powered by AI.

Current Price
$37.80
Sector
Healthcare
What is the BenQ Medical Technology Corporation stock price forecast?

BenQ Medical Technology Corporation is currently trading at $37.80. View real-time AI analysis on Alpha Lenz.

What is BenQ Medical Technology Corporation insider trading activity?

View the latest insider trading data for BenQ Medical Technology Corporation on Alpha Lenz.

What is BenQ Medical Technology Corporation's P/E ratio?

View BenQ Medical Technology Corporation's valuation metrics on Alpha Lenz.

BenQ Medical Technology Corporation

TWSE · 4116
NT$37.80+0.50(+1.34%)
Ask about BenQ Medical Technology Corporation's future dividend policy...
Alpha Chat Insight

BenQ Medical Technology Corporation's ROE is 7.0%. Explore profitability and growth together.

Ask for details

Company Overview

BenQ Medical Technology Corporation is a healthcare equipment and technology company specializing in the design, manufacture, and distribution of advanced medical devices and consumables. Established in 1989 and headquartered in Taipei, the company has developed a diverse portfolio that includes products such as operating tables, surgical lights, ultrasound systems, medical display monitors, protective and medical masks, and the proprietary IQOR integrated systems. BenQ Medical Technology serves hospitals, clinics, and healthcare professionals across Taiwan, Mainland China, India, and more than 50 countries worldwide, emphasizing high product quality, technological innovation, and comprehensive international certifications such as GMP, ISO9001, ISO13485, CE, and ETL. In addition to manufacturing, the firm participates in equipment leasing, information software retailing, medical drug sales, and management consultation, further extending its role within the healthcare value chain. Known for its commitment to research and development, BenQ Medical Technology continues to play a significant role in advancing medical infrastructure and supporting the operational needs of major medical institutions globally.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$5.25BRevenue
0.00Shares Out
0Employees

Margins

32.16%Gross
12.41%EBITDA
6.59%Operating
6.37%Pre-Tax
4.14%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

21.20%Rev 3Yr
30.26%Rev 5Yr
24.54%Op Inc 3Yr
28.87%Op Inc 5Yr
-2.75%Net Inc 3Yr
20.94%Net Inc 5Yr

Returns

4.06%ROA
6.95%ROE
7.07%ROIC

Financial Health

NT$949.33MCash & Cash Equivalents
NT$2.17BNet Debt
133.86%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

BenQ Medical Technology Corporation (ticker: 4116) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 37.8 with a P/E ratio of -x and P/B of -x.

ROE is 6.95% and operating margin is 6.59%. Annual revenue is $5.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
BenQ Medical Technology Corporation (4116) Stock Forecast 2026 $37.80 — Price, Financials & Analyst Targets | Alpha Lenz